+91 935-560-8010 [email protected]
Dr. P Vijay Anand Reddy

(Radiation Oncologist)

Speciality

Surgical Oncology

Experience

31 Years

Location

Hyderabad

Check Availability Mon - Tue, Thu - Fri ( 09:00 AM - 06:00 PM)

4.1

64* Reviews

Biography

Dr. P Vijay Anand Reddy is a highly qualified Ophthalmologist with over 31 years of experience, specializing in ocular oncology.

Dr. Reddy's qualifications include fellowships in Germany and the USA, DNB and MD from Osmania Medical College, Hyderabad, and an MBBS from Osmania University, Hyderabad.

Dr. Reddy has extensive experience treating tumors, including ocular conditions, with various procedures, from prostate cancer radiation to pediatric oncology.

Dr. Reddy is a member of prestigious organizations like ASCO, ESMO, ASTRO, AROI, and ISO. He's a top oncologist in India, having successfully treated 1,000+ international patients from various countries.

Patients can meet doctor at Apollo Hospitals, Jubilee Hills, Hyderabad on Mon - Tue & Thu - Fri at 09:00 AM - 06:00 PM and Wed at 11:00 AM - 06:00 PM.

Special Interest

Hormone Therapy For Breast Cancer, Hormone Therapy For Prostate Cancer, Pap Smear Medical Oncology, Pediatric Oncology

Education

MBBS, MD - Radiotherapy, DNB - Radiotherapy


Frequently Asked Questions About Doctors

1 - Dr. Vijay Anand Reddy Palkonda practices at Apollo Hospitals - Jubilee Hills.

2 - Patients frequently visit Dr. Vijay Anand Reddy Palkonda for External Beam Radiation For Prostate Cancer

3 - Dr. Vijay Anand Reddy Palkonda specialises as Radiation Oncologist.

Latest Blogs

Mommy Makeover Price in UAE - United Arab Emirates

Mommy Makeover Price in UAE - United Arab Emirates can vary significantly depending on various facto...

Read More...

Managing PCOS Disease with Ayurveda

PCOS is a condition that affects 8-13% of women who are of reproductive age. Worldwide, up to 70% of...

Read More...

Knowing About The Top 10 Cardiologists in India

Cardiac deaths is one of the biggest causes of death worldwide, including in India, is still cardiov...

Read More...